ABCC1/MRP1 overexpression has been observed in several types of glioma, including GBMs, GBMs with an oligodendroglial component (GBMO) [347], anaplastic astrocytomas (grade III) [343], and meningiomas [66]. This evidence concerns the gene ABCC1 and central nervous system cancer.